Humacyte, Inc. (HUMA)
0.6424
+0.05
(+8.53%)
USD |
NASDAQ |
Apr 02, 16:00
0.6628
+0.02
(+3.18%)
After-Hours: 20:00
Humacyte EPS Diluted (Quarterly) : -0.1328 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Align Technology, Inc. | 1.892 |
| Eli Lilly & Co. | 7.024 |
| Hims & Hers Health, Inc. | 0.0893 |
| Becton, Dickinson & Co. | 1.336 |
| Boston Scientific Corp. | 0.4493 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -24.80M |
| Revenue (Quarterly) | 0.467M |
| Total Expenses (Quarterly) | 25.27M |
| Enterprise Value | 156.83M |
| Gross Profit Margin (Quarterly) | -2.23K% |
| Profit Margin (Quarterly) | -5.31K% |
| Earnings Yield | -32.18% |
| Normalized Earnings Yield | -92.43 |